In addition, the cell of origin is another potential factor in disease variability highlighted by the fact that transplantation of a late onset CML like disease driven by p210 BCR-ABL in a BM transduction/transplant model led to not only myeloid disease, but also B and T ALL (54). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.